AI Portfolio Summary
In 2025 Q4, ACUTA CAPITAL PARTNERS, LLC maintained a portfolio of 35 distinct positions. The most significant new addition to the portfolio was MINERVA NEUROSCIENCE, which now represents 1.94% of the total fund value. They heavily accumulated shares in TERNS PHARMACEUTICAL, increasing their position by 26.7%. Conversely, ACUTA CAPITAL PARTNERS, LLC completely exited their position in TOURMALINE BIO INC.
Total Positions
35
Quarter
2025 Q4
Top Holding
TERN (17.5%)
Top 10 Concentration
79.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 35
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERN
TERNS PHARMACEU...
|
Healthcare | 17.48% | 3.90% |
#1
8
Prev: #9
|
8.5 | 134,298 | 26.7% |
P
S
|
637,095 | $25,738,638 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 16.62% | 2.72% |
#2
10
Prev: #12
|
8.5 | 33,285 | 66.9% |
P
S
|
83,036 | $24,474,031 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 13.37% | 14.01% |
#3
1
Prev: #2
|
5.0 | -52,384 | -37.0% |
P
S
|
89,145 | $19,691,239 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 8.68% | 14.08% |
#4
3
Prev: #1
|
4.5 | -112,211 | -9.6% |
P
S
|
1,052,995 | $12,783,359 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 5.60% | 6.70% |
#5
1
Prev: #4
|
3.7 | no change | no change |
P
S
|
3,410,402 | $8,253,173 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 4.48% | 5.32% |
#6
Prev: #6
|
2.3 | -398 | -0.5% |
P
S
|
84,477 | $6,592,585 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 3.99% | 3.04% |
#7
4
Prev: #11
|
4.1 | 253,210 | 30.1% |
P
S
|
1,093,300 | $5,871,021 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 3.35% | 3.42% |
#8
2
Prev: #10
|
3.3 | 3,894 | 15.5% |
P
S
|
29,008 | $4,931,360 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 3.06% | 5.74% |
#9
4
Prev: #5
|
1.2 | -12,714 | -32.9% |
P
S
|
25,878 | $4,503,807 | 2014 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGEN SE - ADR
|
Healthcare | 2.77% | 4.86% |
#10
3
Prev: #7
|
1.1 | -1,528 | -24.0% |
P
S
|
4,851 | $4,079,448 | 2017 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
SURROZEN INC
|
Healthcare | 2.74% | 2.38% |
#11
2
Prev: #13
|
2.1 | no change | no change |
P
S
|
178,415 | $4,032,179 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 2.73% | 4.68% |
#12
4
Prev: #8
|
2.1 | no change | no change |
P
S
|
333,258 | $4,025,757 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NERV
MINERVA NEUROSC...
|
Healthcare | 1.94% | — |
#13
Prev: #—
|
4.3 | 709,500 | no change |
NEW
|
709,500 | $2,852,190 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.70% | — |
#14
Prev: #—
|
4.2 | 282,732 | no change |
NEW
|
282,732 | $2,505,006 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 1.70% | 1.54% |
#15
2
Prev: #17
|
1.7 | no change | no change |
P
S
|
454,827 | $2,501,549 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 1.43% | 1.41% |
#16
3
Prev: #19
|
1.6 | no change | no change |
P
S
|
80,143 | $2,110,165 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 1.38% | 1.85% |
#17
1
Prev: #16
|
1.6 | no change | no change |
P
S
|
101,777 | $2,032,487 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 0.96% | — |
#18
Prev: #—
|
3.9 | 150,906 | no change |
NEW
|
150,906 | $1,415,498 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 0.88% | 0.57% |
#19
4
Prev: #23
|
1.4 | no change | no change |
P
S
|
16,377 | $1,293,783 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 0.76% | 0.99% |
#20
2
Prev: #22
|
1.3 | no change | no change |
P
S
|
2,296 | $1,118,726 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.75% | 1.31% |
#21
1
Prev: #20
|
1.3 | no change | no change |
P
S
|
143,446 | $1,107,403 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 0.56% | — |
#22
Prev: #—
|
3.7 | 20,000 | no change |
NEW
|
20,000 | $828,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.53% | — |
#23
Prev: #—
|
3.7 | 59,280 | no change |
NEW
|
59,280 | $781,310 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.53% | — |
#24
Prev: #—
|
3.7 | 67,451 | no change |
NEW
|
67,451 | $780,408 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.47% | 1.02% |
#25
4
Prev: #21
|
0.2 | -8,292 | -33.2% |
P
S
|
16,708 | $688,537 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRML
TOURMALINE BIO ...
|
Unknown | 0.00% | 13.27% |
Sold All 😨
(Was: #3) |
0.0 | -268,451 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHA-AD...
|
Healthcare | 0.00% | 2.01% |
Sold All 😨
(Was: #14) |
0.0 | -9,792 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.00% | 1.93% |
Sold All 😨
(Was: #15) |
0.0 | -10,573 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.00% | 1.53% |
Sold All 😨
(Was: #18) |
0.0 | -102,907 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 0.54% |
Sold All 😨
(Was: #24) |
0.0 | -57,141 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 35 holdings